Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 14/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 12/20 | 0.46 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9133802 | 0.88 | HSD17B1 (0.47) | HSD17B1HSD17B2GPBAR1ALDH1A1TP53 | |
| SCHEMBL9134167 | 0.85 | HSD17B1 (0.47) | HSD17B1HSD17B2GPBAR1NPC1RAB9A | |
| SCHEMBL9133185 | 0.83 | HSD17B1 (0.46) | HSD17B1HSD17B2GPBAR1NPC1RAB9A | |
| SCHEMBL9510820 | 0.82 | HSD17B1 (0.51) | HSD17B1HSD17B2GPBAR1ALDH1A1TP53 | |
| SCHEMBL9137616 | 0.77 | RAB9A (0.49) | ALDH1A1MAPTNPC1RAB9ATDP1 | |
| SCHEMBL9512940 | 0.73 | HSD17B1 (0.51) | HSD17B1HSD17B2GPBAR1ALDH1A1TP53 | |
| SCHEMBL9512980 | 0.72 | HSD17B1 (0.52) | HSD17B1HSD17B2GPBAR1ALDH1A1TP53 | |
| SCHEMBL9136302 | 0.70 | ACR (0.50) | ALDH1A1TP53MAPTSMN1; SMN2HPGD | |
| SCHEMBL9133135 | 0.69 | HSD17B1 (0.46) | HSD17B1HSD17B2ALDH1A1TP53MAPT | |
| SCHEMBL20041120 | 0.67 | ALDH1A1 (0.59) | HSD17B1HSD17B2ALDH1A1TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5464860-A | Antiepileptic agents | NOVAPHARME (FR) | 1995-11-07 | — | — | US | disclosed |
| US-5258397-A | FOR TREATMENT OF EPILEPSY; SIDE EFFECT REDUCTION | NOVAPHARME (FR) | 1993-11-02 | — | — | US | disclosed |